226 related articles for article (PubMed ID: 2944575)
41. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
van de Griend RJ; Ronteltap CP; Gravekamp C; Monnikendam D; Bolhuis RL
J Immunol; 1986 Mar; 136(5):1700-7. PubMed ID: 3005399
[TBL] [Abstract][Full Text] [Related]
42. Direct antiproliferative effects of recombinant human interferon-alpha B/D hybrids on human tumor cell lines.
Fidler IJ; Heicappell R; Saiki I; Grutter MG; Horisberger MA; Nuesch J
Cancer Res; 1987 Apr; 47(8):2020-7. PubMed ID: 3828990
[TBL] [Abstract][Full Text] [Related]
43. The induction of class I HLA by interferon-alpha is independent of the cell cycle, but the expression is enhanced by a G1/S block.
Erusalimsky JD; Gilmore D; Milstein C
Eur J Immunol; 1987 May; 17(5):623-8. PubMed ID: 3108014
[TBL] [Abstract][Full Text] [Related]
44. Selective interferon-induced enhancement of tumor-associated antigens on a spectrum of freshly isolated human adenocarcinoma cells.
Guadagni F; Schlom J; Johnston WW; Szpak CA; Goldstein D; Smalley R; Simpson JF; Borden EC; Pestka S; Greiner JW
J Natl Cancer Inst; 1989 Apr; 81(7):502-12. PubMed ID: 2466127
[TBL] [Abstract][Full Text] [Related]
45. Antibodies to a surface membrane marker from human mammary carcinoma cell line.
Kamiyama M; Hashim GA; Abdelaal A; Araujo L
Cancer Res; 1987 May; 47(9):2433-9. PubMed ID: 3567928
[TBL] [Abstract][Full Text] [Related]
46. Delineation of three subsets of class I human T antigens (HTA) on Molt-4 cells: serologic and regulatory relationship to HLA class I antigens.
Kahn-Perles B; Wietzerbin J; Caillol DH; Lemonnier F
J Immunol; 1985 Mar; 134(3):1759-65. PubMed ID: 2578520
[TBL] [Abstract][Full Text] [Related]
47. Heterogeneity of the induction of HLA-DR expression by human immune interferon on glioma cell lines and their clones.
Piguet V; Carrel S; Diserens AC; Mach JP; de Tribolet N
J Natl Cancer Inst; 1986 Feb; 76(2):223-8. PubMed ID: 3080635
[TBL] [Abstract][Full Text] [Related]
48. Evidence for the elevation of serum carcinoembryonic antigen and tumor-associated glycoprotein-72 levels in patients administered interferons.
Greiner JW; Guadagni F; Goldstein D; Borden EC; Ritts RE; Witt P; LoBuglio AF; Saleh MN; Schlom J
Cancer Res; 1991 Aug; 51(16):4155-63. PubMed ID: 1907881
[TBL] [Abstract][Full Text] [Related]
49. Differential gamma-interferon response of human colon carcinoma cells: inhibition of proliferation and modulation of immunogenicity as independent effects of gamma-interferon on tumor cell growth.
Pfizenmaier K; Bartsch H; Scheurich P; Seliger B; Ucer U; Vehmeyer K; Nagel GA
Cancer Res; 1985 Aug; 45(8):3503-9. PubMed ID: 3160456
[TBL] [Abstract][Full Text] [Related]
50. Interferon-gamma modulates HLA class II antigen expression on cultured human thymic epithelial cells.
Berrih S; Arenzana-Seisdedos F; Cohen S; Devos R; Charron D; Virelizier JL
J Immunol; 1985 Aug; 135(2):1165-71. PubMed ID: 3925000
[TBL] [Abstract][Full Text] [Related]
51. Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions.
Taramelli D; Fossati G; Mazzocchi A; Delia D; Ferrone S; Parmiani G
Cancer Res; 1986 Jan; 46(1):433-9. PubMed ID: 3079589
[TBL] [Abstract][Full Text] [Related]
52. Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer.
Edwards DP; Grzyb KT; Dressler LG; Mansel RE; Zava DT; Sledge GW; McGuire WL
Cancer Res; 1986 Mar; 46(3):1306-17. PubMed ID: 3510721
[TBL] [Abstract][Full Text] [Related]
53. Additive and differential biological activity of alpha-interferon A, difluoromethylornithine, and their combination on established human lung cancer cell lines.
Bepler G; Carney DN; Nau MM; Gazdar AF; Minna JD
Cancer Res; 1986 Jul; 46(7):3413-9. PubMed ID: 3085922
[TBL] [Abstract][Full Text] [Related]
54. Specific membrane receptors for human interferon-gamma (IFN-gamma).
Ucer U; Scheurich P; Bartsch H; Berkovic D; Ertel C; Pfizenmaier K
Behring Inst Mitt; 1987 Jun; (81):88-97. PubMed ID: 2958000
[TBL] [Abstract][Full Text] [Related]
55. Enhancement by interferon of membrane HLA antigens in patients with combined immunodeficiency with defective HLA expression.
Durandy A; Virelizier JL; Griscelli C
Clin Exp Immunol; 1983 Apr; 52(1):173-8. PubMed ID: 6190592
[TBL] [Abstract][Full Text] [Related]
56. Mechanisms of lymphocyte adhesion to human vascular endothelial cells in culture. T lymphocyte adhesion to endothelial cells through endothelial HLA-DR antigens induced by gamma interferon.
Masuyama J; Minato N; Kano S
J Clin Invest; 1986 May; 77(5):1596-605. PubMed ID: 3084562
[TBL] [Abstract][Full Text] [Related]
57. Enhanced expression of HLA molecules and stimulation of autologous human tumor infiltrating lymphocytes following transduction of melanoma cells with gamma-interferon genes.
Ogasawara M; Rosenberg SA
Cancer Res; 1993 Aug; 53(15):3561-8. PubMed ID: 8101762
[TBL] [Abstract][Full Text] [Related]
58. Independent sensitivity of human tumor cell lines to interferon and double-stranded RNA.
Hubbell HR; Liu RS; Maxwell BL
Cancer Res; 1984 Aug; 44(8):3252-7. PubMed ID: 6204744
[TBL] [Abstract][Full Text] [Related]
59. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.
Geppert TD; Lipsky PE
J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267
[TBL] [Abstract][Full Text] [Related]
60. Expression and function of class II antigens on gastric carcinoma cells and gastric epithelia: differential expression of DR, DQ, and DP antigens.
Sakai K; Takiguchi M; Mori S; Kobori O; Morioka Y; Inoko H; Sekiguchi M; Kano K
J Natl Cancer Inst; 1987 Nov; 79(5):923-32. PubMed ID: 2960847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
